IFR US ECM PRICINGS
Mobileye (Israel, mobility software) ─ $825m FO. 50m shares (Secondary) at $16.50 versus $17.32 last sale and $18.64 at launch. GS, BOFA. Upsized from 45m shares. Company concurrently bought back an additional $100m of stock (6.2m shares) from selling shareholder Intel.
Rhythm Pharmaceuticals (US, biotech) ─ $175m ABB. 2.1m shares (Primary) at $85.00 versus $84.00-$89.00 marketing and $89.00 last sale. MS, BOFA, STFL, WF. Upsized from $150m.
Soleno Therapeutics (US, biotech) ─ $200m FO. 2.35m shares (Primary) at $85.00 versus $85.00 fixed price marketing and $88.49 last sale. GS, GUGG. Priced pre-market open. Wall cross.